title: [Subjective stress of adjuvant chemotherapy in breast cancer patients].
abstract: 50 patients, suffering from carcinoma of the breast pT1-3 with concomitant metastatic affection of the lymph nodes with no evidence of distant metastases, and who received adjuvant chemotherapy (either CMF od AC/EC) were examined. Somatic and psychic interferences, the feeling of well-being and general condition, as well as a critical estimation of the clinical situation were assessed. Besides nausea and vomiting, and still prior to hair fall out, chemotherapy activated the memory of the carcinoma. 92% of the patients agreeing to chemotherapy described their decision as having been based exclusively on the medical information. Nevertheless, 30% feel insufficiently informed, so the fear of side effects, the waiting period prior to application, and the confrontation with the seriously ill, were described as a negative experience. An optimistic view with respect to improving the prognosis of the disease were correlated with chemotherapy: 74% would agree to a further chemotherapy. Psychic abnormalities, e.g. depressions, could not be shown following chemotherapy when compared to a reference population.
authors.affiliation: Frauenklinik II Zentralkrankenhaus St.-Jürgen-Strasse Bremen.
authors.forename: M
authors.initials: M
authors.lastname: Krohn
authors.forename: G
authors.initials: G
authors.lastname: Trams
mesh_terms: D000223:Adaptation, Psychological; D000275:Adjustment Disorders / Q000523:psychology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000523:psychology; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects / Q000523:psychology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D010353:Patient Education as Topic; D012803:Sick Role; D012931:Social Environment
vernacular_title: Subjektive Belastung einer adjuvanten Chemotherapie bei Mammakarzinom-Patientinnen.